Product Overview

AOP Orphan's focus is on Rare Diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to Rare Diseases.



is used to reduce an elevated blood platelet count, thrombocyte count, in patients with essential thrombocythemia.

Drug Facts
Active Ingredient